Abstract
Major depressive disorder is characterized by the deficiencies of monoamine neurotransmitters, neurotrophic factors and persistent neuroinflammation. Microglial activation has been associated with neuroinflammation-related mental diseases, accompanied by NLR family pyrin domain containing 3 (NLRP3) inflammasome. Here, we investigated the effect of NLRP3 inhibition by its small molecular inhibitor MCC950 on inflammatory activity and depressive-like mice induced by chronic unpredictable mild stress (CUMS), followed by the behavioral tests including sucrose preference test and forced swimming test. NLRP3/caspase-1/IL-1β signaling and microglial morphology in the prefrontal cortex were measured. The results showed that CUMS caused a decrease in sucrose preference and an increase in immobility time, which were reversed by NLRP3 inhibitor MCC950. In addition, NLRP3 inhibition decreased the number of microglia and changed the activated state of microglia to a resting state by morphology 3D reconstruction. Moreover, NLRP3 inhibition inactivated NLRP3/caspase-1/IL-1β signaling in the prefrontal cortex. The results from immunofluorescence demonstrated that NLRP3 and IL-1β expression was decreased in microglia in response to MCC950 treatment. Accordingly, proinflammatory cytokines were also decreased by NLRP3 inhibition. In conclusion, this study demonstrates that microglial NLRP3 inhibition prevents stress-induced neuroinflammation in the prefrontal cortex and suggests that microglial NLRP3 could be one of the potential therapeutic targets for depression treatment.
Graphic Abstract
Similar content being viewed by others
References
Bhattacharya A, Jones DNC (2018) Emerging role of the P2X7-NLRP3-IL1beta pathway in mood disorders. Psychoneuroendocrinology 98:95–100
Bygdeman S, Kallings I, Danielsson D (1981) Serogrouping and auxotyping for epidemiological study of beta-lactamase-producing Neisseria gonorrhoeae strains isolated in Sweden. Acta Derm Venereol 61:329–334
Cheng J, Chen M, Zhu JX, Li CF, Zhang QP, Geng D, Liu Q, Yi LT (2019) FGF-2 signaling activation in the hippocampus contributes to the behavioral and cellular responses to puerarin. Biochem Pharmacol 168:91–99
Coll RC et al (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21:248–255
Cornell J, Salinas S, Huang HY, Zhou M (2022) Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res 17:705–716
Dempsey C, Araiz AR, Bryson KJ, Finucane O, Larkin C, Mills EL, Robertson AAB, Cooper MA, O’Neill LAJ, Lynch MA (2017) Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-beta and cognitive function in APP/PS1 mice. Brain Behav Immun 61:306–316
Dolunay A, Senol SP, Temiz-Resitoglu M, Guden DS, Sari AN, Sahan-Firat S, Tunctan B (2017) Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-kappaB, Caspase-1/11, ASC, NOX, and NOS Isoforms. Inflammation 40:366–386
Dong Y, Li S, Lu Y, Li X, Liao Y, Peng Z, Li Y, Hou L, Yuan Z, Cheng J (2020) Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice. J Neuroinflammation 17:205
Du RH, Tan J, Sun XY, Lu M, Ding JH, Hu G (2016) Fluoxetine Inhibits NLRP3 Inflammasome Activation: Implication in Depression. Int J Neuropsychopharmacol 19
Goshen I, Yirmiya R (2009) Interleukin-1 (IL-1): a central regulator of stress responses. Front Neuroendocrinol 30:30–45
Hellwig S, Brioschi S, Dieni S, Frings L, Masuch A, Blank T, Biber K (2016) Altered microglia morphology and higher resilience to stress-induced depression-like behavior in CX3CR1-deficient mice. Brain Behav Immun 55:126–137
Himmerich H, Patsalos O, Lichtblau N, Ibrahim MAA, Dalton B (2019) Cytokine research in depression: principles, challenges, and open questions. Front Psychiatry 10:30
Idova GV, Markova EV, Gevorgyan MM, Al’perina EL, Zhanaeva SY (2018) Cytokine production by splenic cells in C57BL/6J mice with depression-like behavior depends on the duration of social stress. Bull Exp Biol Med 164:645–649
Ising C et al (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575:669–673
Ismael S, Nasoohi S, Li L, Aslam KS, Khan MM, El-Remessy AB, McDonald MP, Liao FF, Ishrat T (2021) Thioredoxin interacting protein regulates age-associated neuroinflammation. Neurobiol Dis 156:105399
Izquierdo P, Shiina H, Hirunpattarasilp C, Gillis G, Attwell D (2021) Synapse development is regulated by microglial THIK-1 K(+) channels. Proc Natl Acad Sci U S A 118
Kelley N, Jeltema D, Duan Y, He Y (2019) The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci 20
Kinoshita S, Koyama R (2021) Pro- and anti-epileptic roles of microglia. Neural Regen Res 16:1369–1371
Krugel U, Fischer J, Radicke S, Sack U, Himmerich H (2013) Antidepressant effects of TNF-alpha blockade in an animal model of depression. J Psychiatr Res 47:611–616
Lang L, Xu B, Yuan J, Li S, Lian S, Chen Y, Guo J, Yang H (2020) GABA-mediated activated microglia induce neuroinflammation in the hippocampus of mice following cold exposure through the NLRP3 inflammasome and NF-kappaB signaling pathways. Int Immunopharmacol 89:106908
Li W, Niu L, Liu Z, Xu X, Shi M, Zhang Y, Deng Y, He J, Xu Y, Wan W, Sun Q, Zhong X, Cao W (2021) Inhibition of the NLRP3 inflammasome with MCC950 prevents chronic social isolation-induced depression-like behavior in male mice. Neurosci Lett 136290
Liu JJ, Wei YB, Strawbridge R, Bao Y, Chang S, Shi L, Que J, Gadad BS, Trivedi MH, Kelsoe JR, Lu L (2020) Peripheral cytokine levels and response to antidepressant treatment in depression: a systematic review and meta-analysis. Mol Psychiatry 25:339–350
Liu MY, Yin CY, Zhu LJ, Zhu XH, Xu C, Luo CX, Chen H, Zhu DY, Zhou QG (2018) Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc 13:1686–1698
Lorentz A, Bischoff SC (2001) Regulation of human intestinal mast cells by stem cell factor and IL-4. Immunol Rev 179:57–60
Lu Y, Xu X, Jiang T, Jin L, Zhao XD, Cheng JH, Jin XJ, Ma J, Piao HN, Piao LX (2019) Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-alpha-induced inflammation in microglia cells. Int Immunopharmacol 67:119–128
Pan Y, Chen XY, Zhang QY, Kong LD (2014) Microglial NLRP3 inflammasome activation mediates IL-1beta-related inflammation in prefrontal cortex of depressive rats. Brain Behav Immun 41:90–100
Prinz M, Jung S, Priller J (2019) Microglia biology: one century of evolving concepts. Cell 179:292–311
Rimmerman N et al (2021) Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation. Mol Psychiatry.
Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201–217
Slavich GM, Sacher J (2019) Stress, sex hormones, inflammation, and major depressive disorder: extending social signal transduction theory of depression to account for sex differences in mood disorders. Psychopharmacology (Berl) 236:3063–3079
Song L, Pei L, Yao S, Wu Y, Shang Y (2017) NLRP3 inflammasome in neurological diseases, from functions to therapies. Front Cell Neurosci 11:63
Szepesi Z, Manouchehrian O, Bachiller S, Deierborg T (2018) Bidirectional microglia-neuron communication in health and disease. Front Cell Neurosci 12:323
Wang Y, Xu Y, Sheng H, Ni X, Lu J (2016) Exercise amelioration of depression-like behavior in OVX mice is associated with suppression of NLRP3 inflammasome activation in hippocampus. Behav Brain Res 307:18–24
Wang Y, Che M, Xin J, Zheng Z, Li J, Zhang S (2020) The role of IL-1beta and TNF-alpha in intervertebral disc degeneration. Biomed Pharmacother 131:110660
Wang YL, Wu HR, Zhang SS, Xiao HL, Yu J, Ma YY, Zhang YD, Liu Q (2021) Catalpol ameliorates depressive-like behaviors in CUMS mice via oxidative stress-mediated NLRP3 inflammasome and neuroinflammation. Transl Psychiatry 11:353
Weber ANR, Bittner ZA, Shankar S, Liu X, Chang TH, Jin T, Tapia-Abellan A (2020) Recent insights into the regulatory networks of NLRP3 inflammasome activation. J Cell Sci 133:jcs248344
Willner P (2017) The chronic mild stress (CMS) model of depression: history, evaluation and usage. Neurobiol Stress 6:78–93
Wu AG, Zhou XG, Qiao G, Yu L, Tang Y, Yan L, Qiu WQ, Pan R, Yu CL, Law BY, Qin DL, Wu JM (2021) Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Ageing Res Rev 65:101202
Xu Y, Sheng H, Bao Q, Wang Y, Lu J, Ni X (2016) NLRP3 inflammasome activation mediates estrogen deficiency-induced depression- and anxiety-like behavior and hippocampal inflammation in mice. Brain Behav Immun 56:175–186
Yang J, Wise L, Fukuchi KI (2020) TLR4 cross-talk with NLRP3 inflammasome and complement signaling pathways in alzheimer’s disease. Front Immunol 11:724
Yankelevitch-Yahav R, Franko M, Huly A, Doron R (2015) The forced swim test as a model of depressive-like behavior. J Vis Exp
Yi LT, Zhang MM, Cheng J, Wan HQ, Li CF, Zhu JX, Zhang QP, Liu Q, Xu GH (2021) Antidepressant-like Effects of Degraded Porphyran Isolated from Porphyra haitanensis. Mol Nutr Food Res 65:e2000869
Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, D’Agostino D, Planavsky N, Lupfer C, Kanneganti TD, Kang S, Horvath TL, Fahmy TM, Crawford PA, Biragyn A, Alnemri E, Dixit VD (2015) The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat Med 21:263–269
Yu Q, Zhao T, Liu M, Cao D, Li J, Li Y, Xia M, Wang X, Zheng T, Liu C, Mu X, Sun P (2021) Targeting NLRP3 inflammasome in translational treatment of nervous system diseases: an update. Front Pharmacol 12:707696
Zhai Y, Meng X, Ye T, Xie W, Sun G, Sun X (2018) Inhibiting the NLRP3 inflammasome activation with MCC950 ameliorates diabetic encephalopathy in db/db mice. Molecules 23
Zhu W, Cao FS, Feng J, Chen HW, Wan JR, Lu Q, Wang J (2017) NLRP3 inflammasome activation contributes to long-term behavioral alterations in mice injected with lipopolysaccharide. Neuroscience 343:77–84
Acknowledgments
This work was supported by the Science Research Foundation of ministry of Health & United Fujian Provincial Health and Education Project for Tacking the Key Research [2019-WJ-38]. We would like to thank Instrumental Analysis Center of Huaqiao University for the help of confocal testing.
Author information
Authors and Affiliations
Contributions
L.Y., J.Z. and C.L. designed the study. Q.L., M.Z., M.G., Q.Z., N.L., J.C., S.W. and G.X. performed the behavioral and biochemical experiments. L.Y. did molecular docking. L.Y., C.L. and J.Z. analyzed the data. L.Y., Q.L. and J.Z. wrote the paper. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethics Approval
All animal procedure was approved by Huaqiao University (A2019018) and in accordance with the published guidelines of the China Council on Animal Care.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Supplementary file1 (WEBM 17987 KB)
Rights and permissions
About this article
Cite this article
Liu, Q., Zhang, MM., Guo, MX. et al. Inhibition of Microglial NLRP3 with MCC950 Attenuates Microglial Morphology and NLRP3/Caspase-1/IL-1β Signaling In Stress-induced Mice. J Neuroimmune Pharmacol 17, 503–514 (2022). https://doi.org/10.1007/s11481-021-10037-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11481-021-10037-0